AI in Medical Diagnostics: A Comparative Cost-Benefit Analysis
Author: Luqman Bin Fahad
Abstract
Healthcare systems worldwide face mounting pressure from aging populations, rising disease burden, and resource constraints. This comprehensive meta-analysis examines the diagnostic accuracy, speed, and cost-effectiveness of artificial intelligence (AI)-powered diagnostic tools compared to traditional human-led diagnosis, with particular focus on disparities between high-income and low- and middle-income countries (LMICs). Based on systematic review of over 200 studies from PubMed, Google Scholar, arXiv, and WHO databases, the evidence reveals significant potential for AI to revolutionize medical diagnostics while highlighting substantial implementation challenges across different economic contexts.
Key Findings
Diagnostic Accuracy: AI vs. Human Performance
The analysis reveals a complex landscape of performance. While AI shows great promise, its accuracy varies significantly across medical specialties when compared to human physicians, especially those with expert-level experience. AI excels in pattern-heavy fields like pathology but may generate more false positives in others like radiology.
Speed and Efficiency: Dramatic Time Reductions
One of the most compelling arguments for AI adoption is the dramatic improvement in efficiency. AI significantly reduces the time required for diagnosis across various domains, from radiology to pathology, leading to substantial workload reductions and potential cost savings for healthcare systems.
Cost-Effectiveness: A Global Divide
The economic impact of AI in diagnostics varies dramatically across different income levels. While high-income countries face high implementation costs, low- and middle-income countries (LMICs) have the most to gain, with potential cost savings of 50-90%. However, these are also the regions facing the greatest barriers, such as lack of infrastructure and funding.
Conclusion & Policy Implications
This meta-analysis demonstrates that AI diagnostic tools offer substantial improvements in accuracy, speed, and cost-effectiveness compared to traditional human-led diagnosis, with the greatest potential benefits for low- and middle-income countries despite significant implementation challenges.
The inverse relationship between country income level and potential AI benefits creates both an opportunity and a challenge for global health equity. Successful AI implementation will require coordinated international efforts that address infrastructure development, capacity building, and algorithm adaptation for diverse populations and healthcare contexts.
The promise of AI in medical diagnostics is substantial, but realizing this potential equitably across global healthcare systems will require thoughtful policy interventions that address not only technological development but also the fundamental infrastructure and capacity building needs that underpin successful implementation.